Search results for: 'Antibody Production Market'

19 Aug 2022  |  North America  |  Market Research

Global Antibody Therapeutics Growth Opportunities

The Evolution of Next-generation Immuno-oncology Therapies for Multiple Tumor Antigens is Poised to Drive Market Growth

Infographics

×

Market growth is likely to be fueled by the growing utilization of cost-effective and efficient continuous manufacturing processes and single-use bioreactors for production, which will also reduce the time between development and commercialization. Favorable regulatory reforms in emerging Asian countries are encouraging the manufacture and introduc...

08 Feb 2016  |  North America  |  Market Research

Global Process and Production Chemicals for Electronics, Forecast to 2021

Extreme Ultraviolet Lithography and Smaller Nodes to Drive Growth in Materials

Infographics

×

This research service identifies the major industry drivers, restraints, regulatory trends, and technology trends affecting the global market for process and production chemicals for electronics. The product segments covered in this research are semiconductor materials and PCB chemicals. Semiconductor materials market is subdivided into fabrication...

This research service evaluates the U.S. research antibodies market during the 2009 to 2016 time period. The research antibodies market includes all antibodies sold for research use only to be used as assay components for detection and quantification of particular targets within a sample. Provided within the study is a detailed history and market o...

30 Mar 2023  |  North America  |  Customer Research

Global Laboratory Product Purchasing Trends, 2022–2023

End–user Perspectives on Laboratory Spending Reveals Modest 2023 Budget Increases Following robust 2022 Spending

Infographics

×

Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey from October to November 2022 examining their laboratories’ product purchasing process in 2022 and expectations for 2023. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. The study presents year-over-...

The U.S. Therapeutic Monoclonal Antibodies Markets is a evolving market undergoing many changes. This research service includes in depth analysis of the total market as well as the various therapeutic classes for which monoclonal antibodies are available. This analysis includes revenue forecasts, product/pipeline analysis, and strategic perspective...

The anaerobic digestion market in the United States and Canada is growing rapidly and will continue expanding. Both countries are leveraging the potential of biogas produced through the anaerobic digestion (AD) of energy crops, agricultural waste, organic waste, and sewage sludge. As national programs aim to reduce methane emissions and align with ...

24 Jul 2020  |  North America  |  Market Research

Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024

Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies

Infographics

×

Key Issues Addressed

With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...

Drug-resistant bacteria, or superbugs, pose a serious threat to human health. Developing new antibacterial drugs requires a great deal of time, effort, expenditure, and scientific research, making it a less-attractive segment for investment by pharmaceutical companies. This research service focuses on the global antibacterial drugs (antibiotics) ma...

This market insight provides data for the global multiple sclerosis (MS) market. The analysis looks at MS pharmaceutical pipeline drugs that are currently in the market as well as any drugs that are in Phase III trials and pose a potential threat to competitors. It offers a competitive analysis of these drugs and the forecasted outcome and impact o...